Elsevier

Nutrition

Volume 73, May 2020, 110564
Nutrition

Review
Stunting is a recognized problem: Evidence for the potential benefits of ω-3 long-chain polyunsaturated fatty acids

https://doi.org/10.1016/j.nut.2019.110564Get rights and content

Abstract

Stunting remains a major nutritional problem worldwide, especially in middle- and low-income countries including Indonesia. A number of nutritional feeding programs to cure stunting are basically addressing the problem of malnutrition. These programs are particularly designed to promote recovery of normal metabolic function and weight gain. The currently available remedial formula for malnutrition contains energy and nutrients to recover the weight, but there is less nutrition that would support optimal functional development of tissues including the central nervous system. Research has documented that sufficient intakes of dietary ω-3 long-chain polyunsaturated fatty acids are important for optimal health throughout the life span, especially brain development and cognition. The aim of this study was to review the evidence for the role of food sources of these fatty acids on children's health and growth. To our knowledge, very little work has been conducted on remedial formulas enriched with ω-3 long-chain polyunsaturated fatty acids for malnutrition and optimal health, highlighting a need for intervention studies investigating the health benefits of the formula for malnutrition and optimal health, which may prevent stunting and also may promote optimal health.

Introduction

Stunting, defined as height-for-age z-score <–2 according to the World Health Organization's (WHO) growth standards remains a major nutritional problem worldwide, especially in middle- and low-income countries, including Indonesia. Stunting occurs in one-third of children <5 y of age and causes 14% of childhood deaths in developing countries [1]. According to the Indonesian national basic health research data [2], the national prevalence of stunting in Indonesia was 37.2%, which was divided into 18% of stunting (z-score <–2 to ≥–3) and 19.2% of severe stunting (z-score <–3). This number increased from the previous national survey in 2010 and 2007, which were 35.6% and 36.8%, respectively. Following the survey, an annual nutritional status monitoring has been conducted under the coordination of the Ministry of Health of Indonesia and found that in 2015, prevalence of stunting in children <5 y of age was 29% [3], which slightly decreased in 2016 of 27.5% [4], but increased in 2017 of 29.5% [5]. More importantly, the prevalence of stunting is not decreasing.

A number of nutritional feeding programs to treat stunting are basically addressing the problem of malnutrition, such as using biofortification, prebiotic foods, and remedial formula such as ready-to-use therapeutic foods (RUTFs) that meet the WHO standard, and formulas known as F-75 and F-100 as well as modified dried skim cotton oil (modisco). The last two formulas are common in the treatment of malnutrition in Indonesia. RUTFs are energy-dense, micronutrient-enhanced pastes with a homogenous mix of lipid-rich foods that can be given directly to the patient without cooking. The nutritional profile of the RUTF is similar to the WHO-recommended therapeutic milk formula used for inpatient therapeutic feeding programs. Currently, the availability of RUTF is supported by UNICEF as a part of a community-based management for acute malnourished children globally [6]. The F-75 is designed to promote recovery of normal metabolic function and nutrition electrolytic balance. Hence, it is initially admitted to inpatients with no adequate appetite or those who have a major medical complication. Rapid weight gain is precarious in this stage, as patients do not gain weight. Once the acute condition is stabilized, it is advised to change the diet to F-100, which enables the patient to recover weight and lean body tissue loss [7].

Children with malnutrition not only need diets containing energy and nutrients to recover their weight, but they also require nutrients that support optimal functional development of tissues, including the central nervous system. A study by Danaei, et al. concluded that the leading risk worldwide for stunting is fetal growth restriction, which is defined as small for gestational age (10.8 million cases of stunting out of 44.1 million) [1]. Hence, sufficient dietary intake of ω-3 long-chain polyunsaturated fatty acids (LCPUFAs) are essential to support normal brain development, especially in the critical periods during pregnancy, lactation, and childhood.

The ω-3 LCPUFAs are involved in various neuronal processes, ranging from regulation of gene transcription to effects on cellular signaling processes [8], and protection against the pathogenesis of retinal diseases [9]. Nutrient deficiency during the brain growth spurt, which is between the last trimester of gestation and the first 2 y of childhood can damage brain function [10].

In the RUTF, as well as the F-75/F-100 and modisco, which are being used to date, the ω-3 LCPUFA composition is limited (Supplementary Tables 1–3). In general, intervention studies that used the F-75/F-100 as well as modisco and RUTF showed an improvement of weight; however, limited data were reported on height. The efficacy of RUTF has been evaluated in a number of studies for treatment of malnourished children, including those in Nigeria [11], Malawi [12], and India [13], and concluded that RUTF significantly improved the weight gain of the children. A study in Indonesia using quasiexperimental pre–post-test with a control group design in outpatient malnourished children ages 6 to 59 mo showed that a 5-wk intervention with F-75/F-100 increased the weight of the children by 507 g compared with the control group, which only gained 80 g [14]. Another study that used a randomized blinded pre–post-test with a control group design of inpatient malnourished children ages 1 to 3 y reported that after a 6-mo intervention, the weight gain in the intervention group, which received modisco with elemental milk formula containing medium chain triacylglycerol (TG) and polymer carbohydrate, was significantly higher (1527 g) than the control group given modisco with regular milk formula (726 g) [15]. Moreover, the data showed that the improvement of weight for height in the intervention group is significantly higher (z-score from –3.59 to –1.57) than in control group (z-score from –3.99 to –2.98) [15].

The effect of LCPUFA substitution for children with malnutrition has been reported in studies by Jones et al. [16] and Hsieh, et al. [17]. The Jones et al. study reported on malnourished children who received high-oleic RUTF made with peanut oil from a high-oleic acid peanut cultivar, hence the ratio of linoleic acid (LA) to α-linolenic acid (ALA) was 1:1. The children had a significantly better weight-for-height (WFH) when they recovered from malnutrition than children who were fed standard RUFT that contained 53 times more LA than ALA, although still marginally below average WFH [16]. The levels of ω-3 eicosapentaenoic acid (EPA) and ω-6 docosapentaenoic acid (DPA) decreased from 3.2% to 2.4% [16]. This indicates that the standard RUTF did not support circulating docosahexaenoic acid (DHA) levels. In contrast, the children with high-oleic RUTF showed increased EPA and DPA and the decreasing of DHA levels during recovery period was protected. Additionally, high-oleic RUTF also induced a reduction in arachidonic acid (AA) levels, indicating that less LA was transformed to AA or that AA was displaced from plasma phospholipids by the increased levels of ω-3 LCPUFAs [16]. The study by Hsieh, et al. showed that DHA levels in red blood cell (RBC) membranes significantly decreased after a 4-wk intervention by standard RUTF (from 5.2 to ∼4%) [17]. In the children receiving fish oil, DHA levels in RBC membranes increased over time to ∼6% to 8%. Only supplementation with fish oil increased EPA levels, whereas flax oil RUTF did not change the overall ratio of ω-6 to ω-3 compared with baseline. This ratio increased with standard RUTF but decreased with the fish oil supplementation compared with the flax oil RUTF [17]. Here, we review the potential benefits of ω-3 LCPUFAs for optimizing growth and development of stunted children.

We reviewed the following:

  • [1]

    ω-3 LCPUFA metabolism to highlight the importance of ω-3 LCPUFAs and not rely on the conversion of ALA to ω-3 LCPUFA;

  • [2]

    The health benefits of ω-3 LCPUFAs (and not ALA) during pregnancy, lactation, and throughout child growth and development;

  • [3]

    The recommended intakes and compare them to actual intakes to highlight the importance of increasing intake of ω-3 LCPUFA;

  • [4]

    How the recommended intakes can be met through various ω-3 LCPUFA-enriched foods; and

  • [5]

    The rationale for the inclusion of ω-3 LCPUFA in RUTF, which may prevent stunting.

Section snippets

ω-3 LCPUFA metabolism

Plants are able to synthesize LA (18:2 ω-6) and ALA (C18:3 ω-3); however, because humans cannot, they need to obtain these PUFAs from their diet. Therefore, they are considered essential fatty acids (EFAs) [18]. The metabolism of these EFAs to the LCPUFAs including AA (20:4 ω-6) in the ω-6 pathway and EPA (20:5 ω-3), DPA (22:5 ω-3) and DHA (22:6 ω-3) from the ω-3 pathway, has been well described [19], [20] and is shown in Figure 1. Δ-6 desaturase is the enzyme in the first step of the pathway

The role of ω-3 LCPUFAs on neurologic development

DHA is a crucial element in the nervous system, which is responsible for development of the sensory, perceptual, cognitive, and motor neural system during the brain growth spurt [9], [32]. It is the most fluidizing compound in the cell membrane [33], which is fundamental for growing membranes [34]. The retina, functionally an extension of the brain, is highly enriched with DHA, especially the retinal photoreceptor outer segment disk membranes [35]. The need for DHA in very early pregnancy has

Foods enriched with ω-3 LCPUFAs

In countries with traditionally low fish consumption as well as for certain individuals or communities for whom consumption of fish is not be suitable or convenient, ω-3–enriched foods could play an important role in meeting the recommendations for ω-3 LCPUFA. Lacto-ovo-vegetarians (LOVs) may obtain a limited amount of ω-3 LCPUFAs from eggs, milk, and dairy products, whereas vegans must rely on in vivo biosynthesis of these fatty acids from ALA, which depend on the ratio of ALA and LA from the

Inclusion of ω-3 LCPUFAs in RUTF rationale

In this study, we reviewed evidence that humans are able to synthesize ω-3 LCPUFAs from ALA, albeit limited, especially to DHA. Therefore, rather than relying on the conversion of ALA to ω-3 LCPUFAs including DHA, it is better to consume preformed ω-3 LCPUFAs. We have provided evidence that ω-3 LCPUFA are vital

  • For neurologic development, especially DHA;

  • From birth to old age, especially DHA;

  • For cognitive development, especially DHA; and

  • To prevent chronic disease in children.

However, ur current

Conclusions

The ω-3 LCPUFA must be obtained from preformed ω-3 LCPUFA (not from the conversion from ALA to DHA), which are provided in fish. However, numerous barriers to consume fish lead to a failure to meet the reference values for fish consumption. A low dose of food enriched with ω-3 LCPUFA can be used as a long-term strategy to achieve the health benefits of ω-3 LCPUFA for optimal health, including for stunted children. Due to the remedial formula to treat stunted children currently lacking on ω-3

Acknowledgment

We are grateful to the Ministry of Research, Technology and Higher Education of the Republic of Indonesia for World Class Professor Program, contract number 123.40/D2.3/KP/2018.

References (159)

  • J.C. McCann et al.

    Is docosahexaenoic acid (DHA), an n-3 long chain polyunsaturated fatty acid, required for normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals: a review

    Am J Clin Nutr

    (2005)
  • R.K. McNamara et al.

    Role of omega-3 fatty acids in brain development andfunction: potential implications for the pathogenesis and prevention of psychopathology

    Prostaglandins Leukot Essen Fatty Acids

    (2006)
  • N.M. Giusto et al.

    Lipid metabolism in vertebrate retinal rod outer segments

    Prog Lipid Res

    (2000)
  • M.T. Clandinin et al.

    Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements

    Early Hum Dev

    (1980)
  • M. Martinez

    Tissue levels of polyunsaturated fatty acids during early human development

    J Pediatr

    (1992)
  • L. Lauritzen et al.

    The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina

    Prog Lipid Res

    (2001)
  • J.D. Carver et al.

    The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects

    Brain Res Bull

    (2001)
  • H. Shimano

    Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes (Review)

    Prog Lipid Res

    (2001)
  • S.M. Donahue et al.

    Oken E Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort

    Am J Clin Nutr

    (2011)
  • J.Y. Bernard et al.

    Maternal plasma phosphatidylcholine polyunsaturated fatty acids during pregnancy and offspring growth and adiposity

    Prostaglandins Leukot Essent Fatty Acids

    (2017)
  • J.R. Hibbeln et al.

    Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study

    Lancet

    (2007)
  • J.R. Drover et al.

    Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid

    Early Hum Dev

    (2011)
  • J. Colombo et al.

    Docosahexaenoic acid (DHA) and arachidonic acid (ARA) balance in developmental outcomes

    Prostaglandins Leukot Essent Fatty Acids

    (2017)
  • G.L. Russo

    Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implication for cardiovascular prevention

    Biochem Pharm

    (2009)
  • N.D. Riediger et al.

    A systemic review of the roles of n-3 fatty acids in health and disease

    J Am Diet Assoc

    (2009)
  • A. Dalton et al.

    A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source

    Prostaglandins Leukot Essent Fatty Acids

    (2009)
  • F. Dangardt et al.

    Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents

    Atherosclerosis

    (2010)
  • K.M. Hawthorne et al.

    Docosahexaenoic acid (DHA) supplementation of orange juice increases plasma phospholipid DHA content of children

    J Am Diet Assoc

    (2009)
  • S. Muthayya et al.

    Effect of fortification with multiple micronutrients and n23 fatty acids on growth and cognitive performance in Indian school children: the CHAMPION (Children's Health and Mental Performance Influenced by Optimal Nutrition) Study

    Am J Clin Nutr

    (2009)
  • M. Murthy et al.

    Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus

    J Lipid Res

    (2002)
  • P. Howe et al.

    Dietary intake of long-chain ω-3 polyunsaturated fatty acids: contribution of meat sources

    Nutrition

    (2006)
  • S.M. Donahue et al.

    Associations of maternal prenatal dietary intake of n-3 and n-6 fatty acids with maternal and umbilical cord blood levels

    Prostaglandins Leukot Essent Fatty Acids

    (2009)
  • G. Danaei et al.

    Risk factors for childhood stunting in 137 developing countries: a comparative risk assessment analysis at global, regional, and country levels

    PLoS Med

    (2016)
  • Basic health research

    (2013)
  • Pocket book on nutrition status monitoring and nutrition performance indicators in 2015

    (2016)
  • Results of nutritional status monitoring and its explanation in 2016

    (2017)
  • Results of monitoring nutritional status in 2017

    (2018)
  • Position paper: Ready-to-use therapeutic food for children with severe acute malnutrition

    (2013)
  • World Health Organization. Management of a severe malnutrition: a manual for physicians and other senior health...
  • J.P. Schuchard et al.

    Significance of long-chain polyunsaturated fatty acids for the development and behaviour of children

    Eur J Pediatr

    (2010)
  • A. Nanjo et al.

    Depletion of dietary n-3 fatty acid affects the level of cyclic AMP in rat hippocampus

    J Nutr Sci Vitaminol

    (1999)
  • S. Isanaka et al.

    Effect of preventive supplementation with ready-to-use therapeutic food on the nutritional status, mortality, and morbidity of children aged 6 to 60 months in Niger: a cluster randomized trial

    JAMA

    (2009)
  • V.R. Wasnik et al.

    Effect of locally made ready-to-use therapeutic food (Mushpro Health Drink Powder–MHDP) for treatment of malnutrition on children aged 6 to 72 months in tribal area of Amravati District of Maharashtra, India: a randomized control trial

    Int J Collab Res Intern Med Public Health

    (2012)
  • Rustina Y. Sulistiyawati et al.

    Giving diet F75 and 100 improved weight of malnourished outpatient children under 5 yo

    J Keperawatan Indonesia

    (2012)
  • R. Irawan

    Difference of recovery speed of malnourished children given modisco milk formula and modisco milk-elemental at Dr Soetomo hospital

    (2005)
  • K.D. Jones et al.

    Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial

    BMC Med

    (2015)
  • J.C. Hsieh et al.

    High-oleic ready-to-use therapeutic food maintains docosahexaenoic acid status in severe malnutrition

    J Pediatr Gastroenterol Nutr

    (2015)
  • U.N. Das

    Essential fatty acids: biochemistry, physiology and pathology

    Biotechnol J

    (2006)
  • W.M.N. Ratnayake et al.

    Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper

    Ann Nutr Metab

    (2009)
  • G.C. Burdge et al.

    Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13 C]α-linolenic acid to longer-chain fatty acids and partitioning towards β-oxidation in older men

    Br J Nutr

    (2003)
  • Cited by (15)

    • Concentration of n-3 polyunsaturated fatty acid glycerides by Candida antarctica lipase A-catalyzed selective methanolysis

      2022, Food Bioscience
      Citation Excerpt :

      n-3 Polyunsaturated fatty acids (n-3 PUFA) are long-chain fatty acids whose health benefits as a food supplement have been widely documented (Rahmawaty & Meyer, 2020).

    • Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development

      2022, Science of the Total Environment
      Citation Excerpt :

      Compared to 4 hpf, the level of polyunsaturated fatty acids (PUFAs) continued to increase when zebrafish were developing. Many PUFAs, such as arachidonic acid (AA, 20:4n6), eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are vital elements to support the development of the nervous system and normal functions of the brain in zebrafish and children (McDougall et al., 2017a, 2017b; Rahmawaty and Meyer, 2020). It has been reported that genes linked to the synthesis of PUFAs, namely fatty acyl desaturase (Fad) and Elovl5- and Elovl2-like elongases, were highly expressed during the early development of zebrafish (Monroig et al., 2009), which correlated with the increasing concentration of PUFAs (e.g. FA (22:6n3) in diacylglycerols (DGs), PEs, and PCs (Fig. 2) in the current study.

    • Optimized endogenous lipid concomitants in flaxseed oil by different oil extraction technologies: Their positive roles in emulsions

      2022, LWT
      Citation Excerpt :

      α-linolenic acid (ALA) is a plant origin ω-3 polyunsaturated fatty acids (ω-3 PUFAs), as well as a metabolic precursor of docosahexaenoic acid (DHA, 22:3n-6) and eicosapentaenoic acid (EPA) in mammals. Epidemiological studies and several randomized control experiments demonstrated the crucial and positive influence of ALA on human health, including normal brain development of infants, improvement in cognition for children, and slowing cognitive decline through aging (Srmhs, Barbara, 2005; Svennerholm, 1968). Although flaxseed oil is rich in ALA (>60%), the bio-accessibility of ALA in flaxseed oil is severely limited due to its high oxidative susceptibility and low DHA/EPA conversion rate (BaKer, Miles, Burdge, Yaqoob, & Calder, 2016; Yu et al., 2017).

    • Advances in bioconversion of spent tea leaves to value-added products

      2022, Bioresource Technology
      Citation Excerpt :

      Polyunsaturated FAs are essential as they are not produced in the human body; however, STL could be an alternate source of these FAs as it contain linoleic acid ω-6 (∼10% of total FAs), α-linolenic acid ω-3 (∼8% of total FAs), γ-linolenic acid ω-6 (∼3% of total FAs), cis-8,11,14-eicosatrienoic acid ω-6 (∼8.5% of total FAs) (Ramdani et al., 2014). The health benefits of these polyunsaturated FAs are well understood as they improve brain health, nerve function, blood clotting and muscle strength (Gammone et al., 2016; Shahidi & Ambigaipalan, 2018; Thota et al., 2018; Rahmawaty and Meyer, 2020). STL of green as well as black tea are reasonable sources of minerals like calcium, potassium, phosphorous, magnesium and manganese (Ramdani et al., 2013; Ramdani et al., 2014).

    • Effect of different structural flaxseed lignans on the stability of flaxseed oil-in-water emulsion: An interfacial perspective

      2021, Food Chemistry
      Citation Excerpt :

      Interests in intake of n-3 polyunsaturated fatty acids (n-3 PUFAs) have escalated in recent years due to the intimate relationship between n-3 PUFAs rich diet and chronic diseases prevention, including cardiovascular diseases, type 2 diabetes mellitus, neurodegenerative disease (Chen, Gnanaraj, C, Seedi, & Teng, 2019; Yu et al., 2017). However, epidemiological studies have highlighted that an insufficient intake of n-3 PUFAs has involved nearly 195 countries and regions (Rahmawaty & Meyer, 2020). Importantly, researchers have proved that α-linolenic acid (ALA), the only essential fatty acid n-3 PUFAs, plays an important role in the health of human throughout the entire lifecycle, such as brain development for baby, the fertility of man and women, and prevention of Alzheimer's disease for elderly people.

    • The potential use of recovered fish protein as wall material for microencapsulated anchovy oil

      2020, LWT
      Citation Excerpt :

      Fish oils are different from other animal and plant oils due to their high content of polyunsaturated fatty acids (PUFA). Many researchers have reported that ω-3 PUFAs, especially EPA (eicosapentaenoic acid, C20: 5ω3) and DHA (docosahexaenoic acid, C22: 6ω3), would have a unique role to play in prevention of coronary artery disease, some types of cancers, rheumatoid arthritis, aging, and ω3 PUFAs improve neurological functions especially in children (Bi et al., 2019; Rahmawaty & Meyer, 2020; Shahidi & Ambigaipalan, 2018). British Nutrition Foundation (1992, pp. 156–157) suggests that consumed diets for a healthy balanced diet should contain at least 0.2 g EPA + DHA per day.

    View all citing articles on Scopus

    SR conceptualized the study and drafted the manuscript. BJM co-authored the manuscript and was involved in drafting and finalizing the manuscript. Both authors contributed to the manuscript, read, and approved the final manuscript.

    View full text